News Archive

Date: 03/12/2012
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness of CYP2D6 testing for deciding whether or not a patient should receive adjuvant tamoxifen for treatment of early-stage breast cancer.
Date: 02/29/2012
Lilly Oncology on Canvas art exhibition, featuring art by cancer survivors, visits the University of Michigan Comprehensive Cancer Center for three weeks in March.
Date: 02/28/2012
Lilly Oncology on Canvas art exhibition, featuring art by cancer survivors, visits the University of Michigan Comprehensive Cancer Center for three weeks in March.
Date: 02/16/2012
National Institute of Health names University of Michigan anesthesiologist Carman Green, M.D. to new Interagency Pain Research Coordinating Committee.
Date: 02/10/2012
Cancer research depends on people volunteering to participate in clinical studies.
Date: 02/08/2012
Chat participants can ask questions of U-M lung cancer doctorWritten by Justin Harris; contact at 734-764-2220 or juaha@umich.edu.
Date: 02/06/2012
Understanding how cancer cells survive is a primary focus of investigation in Elizabeth R. Lawlor's researchWritten by Margarita Wagerson; contact at 734-764-2220.
Date: 01/31/2012
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers.
Date: 01/25/2012
Researchers at the University of Michigan, led by Max Wicha, M.D., have found that Avastin, Sutent increase breast cancer stem cells. This could explain the limited success of anti-angiogenesis treatments in breast cancer.
Date: 01/20/2012
University of Michigan Health System is first U.S. academic site to put GE's Veo, which greatly reduces the amount of radiation exposure and therefore, cancer risk, into clinical use.

Pages